This tool was born out of Ro's history of fighting for patients, including its efforts to simplify insurance navigation and approvals, helping patients maximize treatment access and get the best possible coverage
Langfristige Ergebnisse zeigen sich nach 23 Wochen regelmiger Anwendung
TL;DR: In a large sample of US Veterans, GLP-1 drugs were associated with reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions, but increased risk of gastrointestinal issues, hypotension (low blood pressure), and some kidney-related conditions
As of right now, the US uses about 80,000 registered chemicals